Literature DB >> 8323329

Aetiology of Crohn's disease.

T T MacDonald1.   

Abstract

Entities:  

Mesh：

Year:  1993        PMID： 8323329      PMCID： PMC1029329          DOI： 10.1136/adc.68.5.623

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  24 in total

1.  Differential expression of CD25 (interleukin-2 receptor) on lamina propria T cells and macrophages in the intestinal lesions in Crohn's disease and ulcerative colitis.

Authors:  M Y Choy; J A Walker-Smith; C B Williams; T T MacDonald
Journal:  Gut       Date:  1990-12       Impact factor: 23.059

2.  Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction.

Authors:  A J Wakefield; A M Sawyerr; A P Dhillon; R M Pittilo; P M Rowles; A A Lewis; R E Pounder
Journal:  Lancet       Date:  1989-11-04       Impact factor: 79.321

3.  Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo.

Authors:  M Fràter-Schröder; W Risau; R Hallmann; P Gautschi; P Böhlen
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

4.  A placebo-controlled, double-blind, randomized trial of cyclosporine therapy in active chronic Crohn's disease.

Authors:  J Brynskov; L Freund; S N Rasmussen; K Lauritsen; O S de Muckadell; N Williams; A S MacDonald; R Tanton; F Molina; M C Campanini
Journal:  N Engl J Med       Date:  1989-09-28       Impact factor: 91.245

5.  Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Groupe d'Etude Thérapeutique des Affections Inflammatoires Digestives.

Authors:  R Modigliani; J Y Mary; J F Simon; A Cortot; J C Soule; J P Gendre; E Rene
Journal:  Gastroenterology       Date:  1990-04       Impact factor: 22.682

6.  Mycobacteria and inflammatory bowel disease. Results of culture.

Authors:  D Y Graham; D C Markesich; H H Yoshimura
Journal:  Gastroenterology       Date:  1987-02       Impact factor: 22.682

7.  Persistent complement activation in submucosal blood vessels of active inflammatory bowel disease: immunohistochemical evidence.

Authors:  T S Halstensen; T E Mollnes; P Brandtzaeg
Journal:  Gastroenterology       Date:  1989-07       Impact factor: 22.682

8.  Interferon-gamma directly affects barrier function of cultured intestinal epithelial monolayers.

Authors:  J L Madara; J Stafford
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

9.  The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection.

Authors:  V Kindler; A P Sappino; G E Grau; P F Piguet; P Vassalli
Journal:  Cell       Date:  1989-03-10       Impact factor: 41.582

10.  Immunohistochemical examination for mycobacteria in intestinal tissues from patients with Crohn's disease.

Authors:  K Kobayashi; M J Blaser; W R Brown
Journal:  Gastroenterology       Date:  1989-04       Impact factor: 22.682
View more
  5 in total

1.  Enhanced absorption of macromolecules. A secondary factor in Crohn's disease.

Authors:  M Malin; E Isolauri; P Pikkarainen; R Karikoski; J Isolauri
Journal:  Dig Dis Sci       Date:  1996-07       Impact factor: 3.199

Review 2.  Hypoxia and metabolic factors that influence inflammatory bowel disease pathogenesis.

Authors:  Louise E Glover; Sean P Colgan
Journal:  Gastroenterology       Date:  2011-05       Impact factor: 22.682

Review 3.  Clinical uses of probiotics for stabilizing the gut mucosal barrier: successful strains and future challenges.

Authors:  S Salminen; E Isolauri; E Salminen
Journal:  Antonie Van Leeuwenhoek       Date:  1996-10       Impact factor: 2.271

4.  Molecular evidence for two forms of Crohn disease.

Authors:  E C Gilberts; A J Greenstein; P Katsel; N Harpaz; R J Greenstein
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

5.  On the etiology of Crohn disease.

Authors:  D Mishina; P Katsel; S T Brown; E C Gilberts; R J Greenstein
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.